Company information:
Gatc Biotech Limited (No: 04978125)
Address: UNIT G1 VALIANT WAY, I54 BUSINESS PARK, WOLVERHAMPTON, WV9 5GB, UNITED KINGDOM
Status: Active
Incorporated: 27-Nov-2003
Accounts Next Due: 30-Sep-2020
Next Confirmation Statement Due: 12-Nov-2020
Industry Class: 71200 - Technical testing and analysis
Current Director: PATRICK JOSEPH KELLY ( DOB: Oct-1962 From: Mar-2018 )
Current Director: ALICE IRENE MILLS ( DOB: Jun-1952 From: Mar-2018 )
Current Secretary: ALICE IRENE MILLS ( From: Dec-2017 )
Resigned Director: MARCUS BENZ ( From: Sep-2007 To: Jun-2018 )
Resigned Director: THOMAS POHL ( From: Nov-2003 To: Sep-2007 )
Resigned Director: PETER POHL ( From: Nov-2003 To: Sep-2017 )
Resigned Director: WILLIAM ANDREW JOSEPH TESTER ( DOB: Jun-1962 From: Nov-2003 To: Nov-2003 )
Resigned Secretary: STEPHEN JOHN HOLDER ( DOB: Mar-1953 From: Nov-2003 To: Dec-2017 )
Resigned Secretary: HOWARD THOMAS ( DOB: May-1945 From: Nov-2003 To: Nov-2003 )
Persons of Significant Control:
Gatc Biotech Ag, 7 Jakob-Stadler-Platz, Konstanz, 78467, Germany: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more (Notified: 2016-04-06, Ceased: 2017-07-06)
Eurofins Scientific S.E., 23 Val Fleuri, Luxembourgh, L-1526, Luxembourg: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2017-07-06)
Company Accounts Summary (£)
| Item | 2016-12 | 2017-12 | 2018-12 | Chart |
|---|---|---|---|---|
| Current assets | 1,747,125 | 1,824,175 | 1,956,492 | 1747125,1824175,1956492 |
| Current assets / Debtors | 1,330,584 | 257,268 | 534,848 | 1330584,257268,534848 |
| Current assets / Cash at bank and on hand | 416,541 | 1,566,907 | 1,421,644 | 416541,1566907,1421644 |
| Net current assets (liabilities) | 451,613 | 557,508 | 1,079,515 | 451613,557508,1079515 |
| Total assets less current liabilities | 451,613 | 557,508 | 1,079,515 | 451613,557508,1079515 |
| Equity / share capital and reserves | 451,613 | 557,508 | 1,079,515 | 451613,557508,1079515 |